1. Home
  2. BMI vs BLCO Comparison

BMI vs BLCO Comparison

Compare BMI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMI
  • BLCO
  • Stock Information
  • Founded
  • BMI 1905
  • BLCO 1853
  • Country
  • BMI United States
  • BLCO Canada
  • Employees
  • BMI N/A
  • BLCO N/A
  • Industry
  • BMI Industrial Machinery/Components
  • BLCO Ophthalmic Goods
  • Sector
  • BMI Industrials
  • BLCO Health Care
  • Exchange
  • BMI Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • BMI 5.6B
  • BLCO 4.9B
  • IPO Year
  • BMI N/A
  • BLCO 2022
  • Fundamental
  • Price
  • BMI $179.95
  • BLCO $15.23
  • Analyst Decision
  • BMI Buy
  • BLCO Hold
  • Analyst Count
  • BMI 7
  • BLCO 11
  • Target Price
  • BMI $238.50
  • BLCO $15.80
  • AVG Volume (30 Days)
  • BMI 292.9K
  • BLCO 492.5K
  • Earning Date
  • BMI 10-16-2025
  • BLCO 10-29-2025
  • Dividend Yield
  • BMI 0.76%
  • BLCO N/A
  • EPS Growth
  • BMI 19.85
  • BLCO N/A
  • EPS
  • BMI 4.59
  • BLCO N/A
  • Revenue
  • BMI $873,926,000.00
  • BLCO $4,891,000,000.00
  • Revenue This Year
  • BMI $13.15
  • BLCO $8.27
  • Revenue Next Year
  • BMI $8.32
  • BLCO $5.73
  • P/E Ratio
  • BMI $39.05
  • BLCO N/A
  • Revenue Growth
  • BMI 11.82
  • BLCO 8.81
  • 52 Week Low
  • BMI $162.17
  • BLCO $10.45
  • 52 Week High
  • BMI $256.08
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • BMI 39.39
  • BLCO 59.83
  • Support Level
  • BMI $175.92
  • BLCO $15.00
  • Resistance Level
  • BMI $181.96
  • BLCO $15.50
  • Average True Range (ATR)
  • BMI 4.41
  • BLCO 0.34
  • MACD
  • BMI 0.65
  • BLCO 0.02
  • Stochastic Oscillator
  • BMI 39.39
  • BLCO 72.03

About BMI Badger Meter Inc.

Badger Meter Inc is an innovator, manufacturer, and marketer of products incorporating flow measurement, quality, control, and other system solutions serving markets. The company's products measure water, oil, chemicals, and other fluids, and provide and communicate timely measurement data. Its product lines include two categories: sales of water meters, radios, software, and related technologies, and water quality monitoring solutions to water utilities (utility water) and sales of meters and other sensing instruments, valves, software, and other solutions for industrial applications in water, wastewater, and other industries (flow instrumentation). It derives a majority of its revenues from the United States.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: